Treatment of refractory multiple myeloma and considerations for future therapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000532:radiotherapy; D013997:Time Factors
D000477:Alkylating Agents; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan